Post-IPO Equity Biotechnology Companies

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

VolitionRx develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.

Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.

Delta 9 Cannabis is a company with a large, expanding production facility licensed to produce and sell medical marijuana.

OncoZenge develops better products for the supportive care of cancer patients.

Rafael Holdings is a company focused on the development of novel cancer therapies.

FOXO Technologies transforms the global longevity insurance industry with a next-generation underwriting protocol.

ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

OssDsign is a medical-technology company developing implants for bone replacement.

Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific

BCAL Diagnostics is a biotechnology company that focuses on the detection of women’s health issues.

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.